UBCNews - Business - Your Chronic Wound-Care Window Is Almost Up - Act Now To Get Medicare Support

Episode Date: December 15, 2025

Hey everyone, welcome back. Today we're getting into something that's gonna affect millions of Americans—Medicare's upcoming changes to wound care coverage. Have you ever wondered how policy shifts ripple through real patient care? KureCare a division of Veracor Group LLC City: Miami Address: 1150 NW 72ND AVE Website: https://curewounds.com

Hey everyone, welcome back. Today we're getting into something that's going to affect millions of Americans. Medicare's upcoming changes to wound care coverage. Have you ever wondered how policy shifts ripple through real patient care? Yeah, it's significant. Starting January 1st, 2026, Medicare is implementing new requirements that will fundamentally change how patients access advanced wound therapies. We're talking about a mandatory four-week standard care trial before any coverage for advanced treatments kicks in. Four weeks. That sounds like a long time when someone's dealing with a non-healing wound. What's driving this change?

The numbers are eye-opening. Medicare spending on skin substitutes for wound care rose from $256 million in 2019 to more than $10 billion in 2024. CMS is trying to address that explosive growth by tightening coverage determinations. 10 billion? That's a massive increase. So they're basically saying, try traditional methods. first before we cover the advanced stuff. Exactly. The new local coverage determination requires proof that standard of care has failed, as well as detailed wound assessments and strong justification for every application of these products.

It's centered on demonstrating medical necessity and appropriateness. Right. And I imagine that's why we're seeing this rush right now. Clinics expanding access before the deadline hits. Who's most affected by this? Medicare beneficiaries dealing with chronic wounds, diabetic foot ulcers, venous leg ulcers, pressure injuries. These are conditions that often don't respond well to basic wound care.

Um, when you're looking at someone like a diabetic patient with a foot ulcer, time really matters. Delays can lead to infections, hospitalizations, even amputations. The stakes are high. So what does this mean for someone who needs treatment today versus someone who waits until February? Well, under current policies, if you qualify for regenerative therapies, you can access them relatively quickly. After January 1st, you'd need to document four weeks of failed conservative treatment first. That's four more weeks of living with a non-healing wound, four more weeks of infection risk, potentially four more weeks of pain and mobility issues.

Um-hum, I see. That waiting period really compounds the problem. It does. You know, I actually had a conversation with a gentleman last month who said he'd been putting off seeing a specialist because he thought his wound would heal on its own. By the time he came in, we were looking at eight months of failed home care. If he'd come in sooner, we could have intervened much earlier. That's sobering. And I guess the irony is, wait four weeks now by policy or wait eight months by procrastination. Neither's a great option. Ha, exactly. Though I'd rather see the four-week mandated wait than eight months of neglect, but ideally, we'd catch these wounds early and treat them aggressively before they become chronic. That point about early intervention

and access timing sets up our next piece, what these regenerative treatments actually deliver in terms of outcomes. But first, a quick word from our sponsor. If you or a loved one is a Medicare beneficiary struggling with a chronic wound, now is the time to learn about your options. Cure Care, a division of Veracore Group, connects patients to regenerative wound care treatments through a nationwide network of over 500 certified specialists. Their platform helps reduce delays and eligibility checks, documentation, and scheduling, so you can access Medicare-covered therapies before new restrictions take effect. Learn more at curewounds.com. Picking up on that access timing question, what kind of results are patients actually seeing with these regenerative treatments?

Reports from providers using these therapies indicate that certain regenerative treatments can accelerate healing by up to 90% in specific cases, with recovery time reduced by a about 60%. Those aren't just statistics. That's the difference between someone getting back to work, back to mobility, versus potentially facing serious complications. 90% faster healing in certain cases. That's substantial. I mean, for someone dealing with a wound that won't close, that has to be life-changing. Definitely. And when I say life-changing, I mean it literally transforms Delhi living. I remember speaking with a woman who'd been managing a venous leg ulcer for eight months with traditional dressings. Once she received regenerative therapy, we saw significant improvement

within weeks. It gave her her life back, honestly. Stories like that really drive home the impact. Now you mentioned documentation earlier. How does that factor into the 2026 changes? Documentation becomes absolutely critical. CMS emphasized that adequate clinical documentation must support the medical necessity and frequency of every skin substitute application. providers will need objective imaging, structured wound measurements, clear tracking of healing progress over time, it's a not just good practice anymore, it's financial defense against audits. So providers need to be prepared too. What should they be doing right now? Three things. Audit your current documentation to ensure it clearly supports medical necessity,

standardized workflows across clinical settings to eliminate variability, and implement digital platforms that align with CMS's framework. The reimbursement environment is tightening, but it also creates opportunity for providers who adopt the right processes now. Makes sense. Let's talk about something that's been a real resource during recent years.

Telemedicine, how does that fit into the future of wound care, especially with these policy changes? That's an important question. During the pandemic, telehealth became essential for patients with mobility issues or those in rural areas. Remote consultations allowed wound care specialists to monitor healing, adjust treatment plans, and catch complications early without requiring patients to travel. But I'm sensing there's uncertainty ahead.

Unfortunately, yes, Medicare's future telemedicine policies remain unclear. If coverage for telemedicine visits is reduced or restricted, patients who rely on remote consultations may face real challenges accessing care. That's particularly concerning, given the new four-war. week waiting period for advanced therapies, regular monitoring during that time is really important. Right, that monitoring piece is key. It is, without consistent oversight during that mandatory four-week trial, you might miss early signs of infection or deterioration, so telemedicine could be a bridge there, but only if the coverage stays in place.

So to everyone listening, if you're a Medicare beneficiary with a chronic wound, what should you be doing right now? Check your eligibility immediately. Understand your coverage options under current policies before the new rules take effect. Consult with wound care specialists who understand both the clinical options and the administrative challenges during this transition. Don't wait until January to find out what your options are. Time is really of the essence here. Any final thoughts on what this shift means for the broader healthcare environment? This change reflects a broader movement toward value-based care and outcome-driven treatment. In other words, Medicare wants to ensure that expensive therapies

are used appropriately and effectively. While that makes fiscal sense, wound care experts like those at cure care caution that we need to balance cost and patient access. The goal should be healing wounds efficiently while maintaining quality care. Well said, this has been really informative. Thanks for breaking down these complex policy changes and what they mean for real people dealing with real health challenges. Thank you for having me. It's a very important. It's a very important. It's a important conversation, and I hope it helps people take action before the deadline. Absolutely. To everyone out there, stay informed, talk to your providers and understand your options. Thanks for listening.